BioForce Nanosciences Holdings, Inc.
BFNH
$0.60
$0.2466.67%
| 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | 09/30/2023 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | 1.99% | -1.66% | -2.15% | -2.80% | -3.93% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 1.99% | -1.66% | -2.15% | -2.80% | -3.93% |
| Operating Income | -1.99% | 1.66% | 2.15% | 2.80% | 3.93% |
| Income Before Tax | -1.99% | 1.66% | 2.15% | 2.80% | 3.93% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -1.99% | 1.66% | 2.15% | 2.80% | 3.93% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -1.99% | 1.66% | 2.15% | 2.80% | 3.93% |
| EBIT | -1.99% | 1.66% | 2.15% | 2.80% | 3.93% |
| EBITDA | -- | -- | -- | -- | -- |
| EPS Basic | -2.48% | 1.22% | 1.82% | 3.01% | 4.17% |
| Normalized Basic EPS | -2.00% | 1.96% | 2.91% | 2.91% | 4.76% |
| EPS Diluted | -1.80% | 0.89% | 1.33% | 2.20% | -12.12% |
| Normalized Diluted EPS | -2.00% | 1.96% | 2.91% | 2.91% | 4.76% |
| Average Basic Shares Outstanding | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Average Diluted Shares Outstanding | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |
